PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus. [electronic resource]
Producer: 20150120Description: 13371-83 p. digitalISSN:- 1529-2401
- Animals
- Animals, Newborn
- Benzimidazoles -- pharmacology
- Calcium -- metabolism
- Calcium Channel Agonists -- pharmacology
- Calcium Signaling -- physiology
- Calcium-Calmodulin-Dependent Protein Kinases -- metabolism
- Calmodulin -- metabolism
- Cells, Cultured
- Enzyme Inhibitors -- pharmacology
- Female
- HEK293 Cells
- Humans
- Intermediate-Conductance Calcium-Activated Potassium Channels -- genetics
- Male
- Membrane Potentials -- drug effects
- Protein Binding -- drug effects
- Protein Kinases -- genetics
- Rats
- Rats, Sprague-Dawley
- Serine -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.